A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
National Cancer Institute (NCI)
Sun Yat-sen University
Hoffmann-La Roche
National Cancer Institute (NCI)
Syndax Pharmaceuticals
University of Virginia
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Syndax Pharmaceuticals
University of Maryland, Baltimore
Syndax Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Syndax Pharmaceuticals
National Cancer Institute (NCI)
Taizhou EOC Pharma Co., Ltd.
Syndax Pharmaceuticals
National Institutes of Health Clinical Center (CC)